Get Connected with Top Clinical Trials
Clinical trials are often the best treatment option for patients with mesothelioma. Learn which trial is right for you.
We proudly support:
Featured Clinical Trials:
-
Combination Immunotherapy Treatment
Researchers in this trial are testing a combination of two immunotherapy drugs: MEDI4736 and tremelimumab. Patients will receive one drug or both, plus surgery.
-
Immunotherapy Treatment With Keytruda
Keytruda (pembrolizumab) is an immunotherapy treatment being tested for mesothelioma. Patients in this trial receive Keytruda, surgery, and chemotherapy.
-
Multimodal Treatment with High-Tech Radiation
This trial tests a multimodal therapy including: pleurectomy with decortication (P/D) surgery, standard chemotherapy, and intensity modulated radiation therapy (IMRT).
We Support
Mesothelioma Survivors Benefit from Clinical Trials
Kendra Ferreira
Type of Mesothelioma
Peritoneal Mesothelioma
Age at time of diagnosis
42
Year diagnosed
2001
Average prognosis for her diagnosis
24 months
An artist from Rhode Island, Kendra Ferreira has enjoyed a great life with three children and a loving husband. She taught art classes and exhibited her artwork. In 2001, Kendra was diagnosed with mesothelioma after noticing her stomach swelling without any weight gain.
She was originally diagnosed with ovarian cancer and had a hysterectomy. Her doctor realized the cancer had originated as peritoneal mesothelioma and spread to the ovaries.
After finding mesothelioma specialists, she took part in a clinical trial surgery, followed by chemotherapy. She was sensitive to many of the chemotherapy blends, but her specialists were able to tailor them to her specific needs, resulting in her recovery. More than a decade later, she is still enjoying good health.
Treatment:
- Clinical trial surgery
- Chemotherapy
